Alsibai Kinan Drak, Daste Ghislaine, Ferlicot Sophie, Fabre Monique, Steenkeste Karine, Salleron Julia, Hammoudi Yacine, Fontaine-Aupart Marie-Pierre, Eschwege Pascal
Service d'Anatomie Pathologique, Centre des Ressources Biologiques, Centre Hospitalier de Cayenne, 97306 Cayenne Cedex, France.
These authors should be considered joint first authors.
World J Oncol. 2020 Oct;11(5):204-215. doi: 10.14740/wjon1305. Epub 2020 Oct 15.
Urinary conventional cytology (UCCy) is easy to perform, but its low sensitivity, especially for low-grade urothelial neoplasms (LGUNs), limits its indications in the management of patients at risk of bladder cancer. The authors aim at obtaining a complementary test that would effectively increase the sensitivity of UCCy on voided urines by analyzing fluorescence of Papanicolaou-stained urothelial cells with no change of method in slide preparation.
In this retrospective study of 155 patients, 91 Papanicolaou-stained voided urines were considered satisfactory under fluorescence microscopy (FMi). The results of FMi were compared with UCCy (using transmission microscopy) and correlated to cystoscopy, histology and follow-up data.
The results are given for all patients and for two groups of them according to the patients' main complaints (group 1: 33 patients followed up for a previously treated bladder tumor; group 2: 58 patients with persistent urinary symptoms). Overall negative predictive value (NPV) and sensitivity of FMi were 100% vs. 73.7% and 64.3% respectively for UCCy (P = 0.0001). Sensitivity of FMi for LGUN was unexpectedly high with a value of 100% vs. 46.2% for UCCy (P = 0.0002). FMi was significantly superior to UCCy for detecting urothelial tumors in every group of patients and would allow a better characterization of atypical urothelial cells (AUCs) defined by the Paris System for Reporting Urine Cytology (TPS).
Because of its sensitivity and NPV of 100%, FMi could complement UCCy to screen voided urines allowing a better detection of primary urothelial tumors or early recurrences of previously treated urothelial carcinoma. Moreover, this "dual screening" would allow completing efficiently cystoscopy to detect flat dysplasia, carcinoma (CIS) and extra bladder carcinoma.
尿细胞学常规检查(UCCy)操作简便,但其低敏感性,尤其是对低级别尿路上皮肿瘤(LGUNs)的低敏感性,限制了其在膀胱癌高危患者管理中的应用。作者旨在获得一种补充检测方法,通过分析巴氏染色尿路上皮细胞的荧光,在不改变玻片制备方法的情况下有效提高UCCy对晨尿的敏感性。
在这项对155例患者的回顾性研究中,91份巴氏染色晨尿在荧光显微镜(FMi)下被认为是满意的。将FMi的结果与UCCy(使用透射显微镜)进行比较,并与膀胱镜检查、组织学和随访数据相关联。
根据患者的主要主诉,给出了所有患者以及其中两组患者的结果(第1组:33例曾接受膀胱肿瘤治疗的患者进行随访;第2组:58例有持续性泌尿系统症状的患者)。FMi的总体阴性预测值(NPV)和敏感性分别为100%,而UCCy分别为73.7%和64.3%(P = 0.0001)。FMi对LGUN的敏感性出人意料地高,为100%,而UCCy为46.2%(P = 0.0002)。在每组患者中,FMi在检测尿路上皮肿瘤方面明显优于UCCy,并且能够更好地对由巴黎尿液细胞学报告系统(TPS)定义的非典型尿路上皮细胞(AUCs)进行特征描述。
由于其100%的敏感性和NPV,FMi可以补充UCCy对晨尿进行筛查,从而更好地检测原发性尿路上皮肿瘤或先前治疗的尿路上皮癌的早期复发。此外,这种“双重筛查”将能够有效地完善膀胱镜检查,以检测扁平发育异常、原位癌(CIS)和膀胱外癌。